These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21838181)

  • 1. Impact of descent and stay at a Dead Sea resort (low altitude) on patients with systolic congestive heart failure and an implantable cardioverter defibrillator.
    Gabizon I; Shiyovich A; Novack V; Khalameizer V; Yosefy C; Moses SW; Katz A
    Isr Med Assoc J; 2011 Jul; 13(7):402-7. PubMed ID: 21838181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Dead Sea: good for the soul, good for the heart.
    Schliamser JE; Amir O
    Isr Med Assoc J; 2011 Jul; 13(7):438-9. PubMed ID: 21838189
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
    De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR
    J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy.
    Belardinelli R; Capestro F; Misiani A; Scipione P; Georgiou D
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):818-25. PubMed ID: 17001224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dead Sea: natural oxygen enrichment at low altitude.
    Kramer MR; Godfrey S
    Isr J Med Sci; 1996 Jul; 32 Suppl():S20-3. PubMed ID: 8756971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of low altitude at the Dead Sea on exercise capacity and cardiopulmonary response to exercise in cystic fibrosis patients with moderate to severe lung disease.
    Falk B; Nini A; Zigel L; Yahav Y; Aviram M; Rivlin J; Bentur L; Avital A; Dotan R; Blau H
    Pediatr Pulmonol; 2006 Mar; 41(3):234-41. PubMed ID: 16429430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Dead Sea and SCHF patients with an ICD.
    Harari M; Abu-Sirhan L
    Isr Med Assoc J; 2012 Jan; 14(1):73; author reply 73. PubMed ID: 22624449
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomized comparison of simultaneous biventricular stimulation versus optimized interventricular delay in cardiac resynchronization therapy. The Resynchronization for the HemodYnamic Treatment for Heart Failure Management II implantable cardioverter defibrillator (RHYTHM II ICD) study.
    Boriani G; Müller CP; Seidl KH; Grove R; Vogt J; Danschel W; Schuchert A; Djiane P; Biffi M; Becker T; Bailleul C; Trappe HJ;
    Am Heart J; 2006 May; 151(5):1050-8. PubMed ID: 16644335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.
    Abraham WT; Young JB; León AR; Adler S; Bank AJ; Hall SA; Lieberman R; Liem LB; O'Connell JB; Schroeder JS; Wheelan KR;
    Circulation; 2004 Nov; 110(18):2864-8. PubMed ID: 15505095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of early comprehensive cardiac rehabilitation following the implantation of cardioverter-defibrillator.
    Śmiałek J; Lelakowski J; Majewski J
    Kardiol Pol; 2013; 71(10):1021-8. PubMed ID: 24197582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of B-type natriuretic peptide, New York Heart Association classification and depression on quality of life in nonhospitalized heart failure patients.
    Ancheta IB; Battie C; Cobb S; Ancheta C; Miller A; Chiong JR
    Prog Cardiovasc Nurs; 2009 Dec; 24(4):124-30. PubMed ID: 20002336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of appropriate defibrillator therapy in heart failure patients treated with cardiac resynchronization therapy.
    Soliman OI; Theuns DA; van Dalen BM; Vletter WB; Nemes A; Jordaens LJ; Balk AH; Ten Cate FJ; Geleijnse ML
    Am J Cardiol; 2010 Jan; 105(1):105-11. PubMed ID: 20102900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depression is a major determinant of quality of life in patients with chronic systolic heart failure in general practice.
    Müller-Tasch T; Peters-Klimm F; Schellberg D; Holzapfel N; Barth A; Jünger J; Szecsenyi J; Herzog W
    J Card Fail; 2007 Dec; 13(10):818-24. PubMed ID: 18068614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population).
    Zareba W; Piotrowicz K; McNitt S; Moss AJ;
    Am J Cardiol; 2005 Jun; 95(12):1487-91. PubMed ID: 15950580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
    Bardy GH; Yee R; Jung W
    J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable cardioverter-defibrillator patients who are upgraded and respond to cardiac resynchronization therapy have less ventricular arrhythmias compared with nonresponders.
    Thijssen J; Borleffs CJ; Delgado V; van Rees JB; Mooyaart EA; van Bommel RJ; van Erven L; Boersma E; Bax JJ; Schalij MJ
    J Am Coll Cardiol; 2011 Nov; 58(22):2282-9. PubMed ID: 22093504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [14-year experience with implantable cardioverter/defibrillators: determination of prognosis and discharge behavior].
    Vester EG; Dees H; Dobran I; Hennersdorf M; Perings C; Heydthausen M; Winter J; Strauer BE
    Z Kardiol; 2000; 89 Suppl 3():194-205. PubMed ID: 10810803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biventricular stimulation therapy in patients with heart failure and tachycardic arrhythmias. Indications--results--prospects].
    Trappe HJ
    Biomed Tech (Berl); 2002 Oct; 47(9-10):243-9. PubMed ID: 12369212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefit of combined resynchronization and defibrillator therapy in heart failure patients with and without ventricular arrhythmias.
    Ypenburg C; van Erven L; Bleeker GB; Bax JJ; Bootsma M; Wijffels MC; van der Wall EE; Schalij MJ
    J Am Coll Cardiol; 2006 Aug; 48(3):464-70. PubMed ID: 16875970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience.
    Sunsaneewitayakul B; Sitthisook S; Sangwatanaroj S; Prechawat S; Songmuang SB
    J Med Assoc Thai; 2007 Jul; 90(7):1458-66. PubMed ID: 17710992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.